TY - JOUR T1 - 12 month results of CALIBER: A phase II randomised feasibility trial of chemoablation with MMC versus surgical management in low risk (LR) non-muscle invasive bladder cancer (NMIBC) JO - European Urology Supplements PY - 2019/03/30 AU - Mostafid H AU - Porta N AU - Cresswell J AU - Griffiths T AU - Kelly J AU - Catto J AU - Davenport K AU - McGrath J AU - Cooke P AU - Masood S AU - Feber A et al ED - DO - DOI: 10.1016/s1569-9056(19)30560-3 PB - Elsevier BV VL - 18 IS - 1 SP - e762 EP - e763 Y2 - 2025/07/20 ER -